About Bellco Capital
Bellco Capital is a private equity firm founded in 2003. It is primarily based in Los Angeles, United States.
Overall Bellco Capital portfolio has seen 2 IPOs and 6 acquisitions, namely Kite Pharma, Allogene Therapeutics and UroGen Pharma. A lot of funds co-invest with Bellco Capital, with names like Vida Ventures sharing a substantial percentage of its portfolio.
Bellco Capital has a team of 6 people.
Key Metrics
Bellco Capital's Portfolio
They have invested in a total of 13 companies. Their most recent investment was in ByHeart (Series C round) on Mar 28, 2024. Here is the most recent investment by Bellco Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Mar 28, 2024 | Series C | 3388 | ||
Jul 09, 2021 | Series B | 3676 | and 5 others | |
Jan 05, 2021 | Series A | 7830 | ||
Sep 29, 2020 | Series B | 1194 |
Here is the portfolio snapshot of Bellco Capital:
Investments by Year
The maximum number of investments were made in 2018
Team profile of Bellco Capital
Bellco Capital has a team of 6 members located in United States. Bellco Capital's team does not sit on the board of any company as of now.Here is a list of all team members in Bellco Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Principal | Los Angeles | - | ||
Associate | Los Angeles | - | ||
Associate | Los Angeles | - | ||
Associate | United States | - |
Co-investors of Bellco Capital
Over the past 23 years, 24 investors have co-invested in Bellco Capital's portfolio companies.
- Top Co-investors of Bellco Capital: 24 investors entered a company along with Bellco Capital. These include investors like Vida Ventures (3 companies).
Bellco Capital News
•
Gemdale USA Secures $90M Refinance for San Diego Life Sciences CampusCommercial Observer•Jul 24, 2026•Tishman Speyer, Bellco Capital
•
DailyPay Announces New $195 Million Senior Secured Revolving Credit FacilityGlobal Fintech Series•Jan 05, 2026•DailyPay, J P Morgan, JPMorgan Chase, Super Micro and 5 others
•
Symbiotic Capital: Life Science Credit Firm Raises Over $600 MillionPulse 2.0•Aug 13, 2024•Symbiotic Capital, Bellco Capital
•
Symbiotic Capital, a First-of-its-Kind Life Science Credit Firm, Launches with More than $600 Million RaisedPR Newswire•Aug 06, 2024•Symbiotic Capital, Bellco Capital, Allogene Therapeutics, Symbiotic Capital and 2 others
•
BYHEART, working in the field of baby nutrition, received an investment of $ 95 millionWebrazzi•May 14, 2024•ByHeart, D1 Capital Partners, Bellco Capital, Polaris Partners and 5 others
•
ByHeart Raises $95M in FundingFinSMEs•May 13, 2024•ByHeart, D1 Capital Group, Bellco Capital, Polaris Partners and 3 others
•
Nuveen Real Estate completes €35m green loan for Amsterdam life sciences developmentNuveen•Feb 07, 2024•Nuveen, Breakthrough Properties, Tishman Speyer, Bellco Capital and 1 other
•
Breakthrough Buys Majority Stake in $236M Life Science CampusCommercial Property Executive•Jan 11, 2024•Breakthrough Properties, Bellco Capital, Healthpeak, callanridge.com
•
Tishman Speyer Receives $750M in Construction Financing for Mixed-Use Project in BostonBetter Built by Barnes•Jun 19, 2023•Tishman Speyer, Otera Capital, Harvard, JLL and 1 other
•
Breakthrough Properties Lands $130M for Philadelphia ProjectCommercial Property Executive•May 04, 2023•Breakthrough Properties, D2 Organization, Corebridge Financial, Bellco Capital and 1 other
